ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1079

Polyclonal CD4+Foxp3+ treg Cells Induce TGFb-Dependent Tolerogenic Dendritic Cells That Suppress Murine Lupus-Like Syndrome

Qin Lan1 and Song G. Zheng2, 1Medicine, University of Southern California, Los Angeles, CA, 2Medicine, Keck School of Medicine of USC, Los Angeles, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: autoimmune diseases, cytokines, Dendritic cells, lupus nephritis and regulatory cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Interplay between Foxp3+ regulatory T cells (Treg) and dendritic cells (DCs) maintains immunologic tolerance, but the effects of each cell on the other are not well understood.

Methods:

Naive CD4+Foxp3- cells isolated from DBA/2 mice were stimulated with anti-CD3/CD28 antibodies with IL-2 and TGF-β to develop polyclonal CD4+ iTregs. These cells were adoptively transferred to D2B6F1 mice that also received D2 spleen cells. Anti-IL-10R, Anti-TGFβ or ALK5 (TGFβRI) inhibitor was administrated in some groups of mice. To determine molecular mechanism, TGFβRII DC conditional KO mice were developed and colitis model was used. DC numbers and phenotypes were determined in chronic lupus mice before and after iTreg or Tcon cell treatment. DC were sorted in iTreg or Tcon treated groups and were adoptively transferred to another lupus mice to determine the therpeutic role of DC subsets. 

Results:

We report that polyclonal CD4+Foxp3+ Treg cells induced ex-vivo with TGFβ (iTreg) suppress a lupus-like chronic graft-versus-host disease by preventing the expansion of immunogenic DCs and inducing protective DCs that generate additional recipient CD4+Foxp3+ cells. The protective effects of the transferred iTreg cells required both IL-10 and TGFβ, but the tolerogenic effects of the iTreg on DCs, and the immunosuppressive effects of these DCs, was exclusively TGFβ-dependent.  The iTreg were unable to tolerize Tgfbr2-deficient DCs. 

Conclusion:

These results support the essential role of DCs in “infectious tolerance” and emphasize the central role of TGFβ in protective iTreg/DCs interactions in vivo.


Disclosure:

Q. Lan,
None;

S. G. Zheng,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/polyclonal-cd4foxp3-treg-cells-induce-tgfb-dependent-tolerogenic-dendritic-cells-that-suppress-murine-lupus-like-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology